Category Archives: Investor state dispute

Why RCEP is the problem, not the solution

Source: inquirer.net | May 17, 2017 On May 2-12, the 16 member-countries of the Regional Comprehensive Economic Partnership (RCEP) met in Manila for their 18th round of negotiations to craft a multilateral trade deal that would affect half of the world’s … Continue reading

Posted in Investor state dispute, IP Rights, ISDS, Regional Comprehensive Economic Partnership, TRIPS plus, TRIPS&IP rights, Uncategorized | Leave a comment

Trade laws that rob common people

Dr Gopal Dabade, Deccan Herald|  May 8 2017 If the RCEP talks materialise, they will give big companies a market access to over 3 billion people. Trade between countries has existed since time immemorial. The World Tr­ade Organisation (WTO) is … Continue reading

Posted in Investor state dispute, IPR Enforcement, ISDS, Regional Comprehensive Economic Partnership, TRIPS plus, Uncategorized, WTO | Leave a comment

MSF response on RCEP negotiations in the Philippines

Source: MSF Access Campaign New Delhi, 8 May 2017 – The Philippines is set to host the 18th round of the Regional Comprehensive Economic Partnership (RCEP) trade agreement’s negotiations in Manila this week. Negotiators from the ten members of the … Continue reading

Posted in Data Exclusivity, Evergreening, Investor state dispute, IPR Enforcement, ISDS, Patent, Patent Term Extension, Regional Comprehensive Economic Partnership, TRIPS, TRIPS plus, Uncategorized, WTO | Leave a comment

Eli Lilly’s ISDS Patent Claim against Canada Defeated

In an unprecedented case, Eli Lilly initiated an amended investor-state-dispute-settlement (ISDS) claim against the government of Canada in 2013 after Canada’s highest courts upheld invalidations on new therapeutic use patents for two chemical compounds – olanzapine and atomoxetine, the active … Continue reading

Posted in Compulsory Licensing, FTA, Investor state dispute, Uncategorized | Leave a comment

Jane Kelsey: Governments in denial of a world changing around them

Source: NZHerald | March 29, 2017 The visit of China’s Premier Le Keqiang to New Zealand should be the catalyst for a mature and nuanced discussion of our future relationship with the world’s rising hegemon, not simply, whether we can renegotiate … Continue reading

Posted in Investor state dispute, Regional Comprehensive Economic Partnership, TPP, Uncategorized | Leave a comment

Panel Rejects Eli Lilly Claim Over Canadian Patent Law, Orders Company to Pay Millions in Costs

In the early 1990s, Eli Lilly applied for patent protection in Canada for two chemical compounds, olanzapine and atomoxetine. The company had already obtained patents over the compounds, but asserted that it had evidence to support new uses for the … Continue reading

Posted in Investor state dispute, NAFTA, Special 301 report, Uncategorized, USTR, USTR 301 report | Leave a comment

RCEP and Health: This Kind of ‘Progress’ is Not What India and the World Need

Source: The Wire Concerns remain over the impact of RCEP negotiations on public health and access to medicines Negotiators from 16 countries are meeting in Kobe, Japan on Monday to begin the 17th round of negotiations of the Regional Comprehensive Economic … Continue reading

Posted in Data Exclusivity, Investor state dispute, IPR, Patent, Patent Term Extension, TRIPS flexibilities, TRIPS plus, TRIPS&IP rights, Uncategorized | Leave a comment